Sameh Mohammed, Islam Nour, Abd Elazeez Shabaan, Basma Shouman, Hesham Abdel-Hady and Nehad Nasef
Mansoura University Childrens Hospital, Egypt
University of Mansoura, Egypt
Posters & Accepted Abstracts: Clinics Mother Child Health
Background: The optimum caffeine dose for apnoea of prematurity (AOP) has not been well investigated. Objective: The main objective of this study is to compare the efficacy and safety of high versus low-dose caffeine citrate on AOP. Methods: Prospective randomized study was conducted on preterm infants <32 weeks gestation, presented with AOP within the first 10 days of life. We compared high-dose (loading 40 mg/kg/day and maintenance of 20 mg/kg/day) versus low-dose (loading 20 mg/ kg/day and maintenance of 10 mg/kg/day) caffeine citrate. The primary outcome was frequency and documented days of apnoea. Secondary outcomes included need for mechanical ventilation in non-ventilated infants; durations of mechanical ventilation, CPAP, and oxygen therapy; extubation failure; length of hospital stay; neonatal mortality; chronic lung disease; necrotizing enterocolitis; intra-ventricular haemorrhage; periventricular leukomalacia; retinopathy of prematurity; and caffeine side effects. Results: A total of 120 neonates (60 in each group) were enrolled. High, compared to low, dose caffeine was associated with a significant reduction in the frequency of apnoea (p<0.001), days of documented apnoea (p<0.001), extubation failure (p<0.05), and duration of oxygen therapy (p=0.04). No significant effect was noted on other secondary outcomes. High- dose caffeine was associated with significant increase in episodes of tachycardia (p< 0.05) without a significant impact on physician decision to withhold caffeine. Conclusion: High-dose caffeine is associated with decreased frequency of apnoea, fewer days of documented apnoea, shorter duration of oxygen therapy, and increased chance of successful extubation without a significant impact on neonatal mortality or morbidity.
E-mail: nehad_nasef@mans.edu.eg